Hemoglobinopathies Treatment Market Size, Share, Industry Analysis | Growth, 2027
Hemoglobinopathies Market Overview
The global hemoglobinopathies market is estimated to drive the market growth owing to
the rising prevalence of hemoglobin disorders such as sickle cell anemia,
thalassemia, Hb C, and Hb E. Also, a low level of hygiene and poor healthcare
infrastructure are some key factors attributing to the growth of the target
population in low-income regions such as South-East Asia, the Mediterranean
basin, and Africa.
However, the lack of treatment and diagnosis
awareness may hamper market growth over the forecast period.
Request Free
Sample Copy at:
https://www.marketresearchfuture.com/sample_request/8098
Hemoglobinopathies
Market Segmentation
The global
hemoglobinopathies market is segmented based on type, treatment, test types,
and region.
The global
market for hemoglobinopathies, by type, is segmented into thalassemia, sickle
cell disease, and other Hb variants diseases. The thalassemia segment is
further classified as alpha thalassemia and beta thalassemia. The sickle cell
disease segment is expected to hold the largest market share of the
hemoglobinopathies market owing to the presence of strong product pipelines such
as LentiGlobin and rising prevalence of sickle cell disease.
Based on
treatment, the market is classified into stem-cell transplantation, blood
transfusions, analgesics, antibiotics, ACE inhibitors, and hydroxyurea. Also,
based on treatment, the blood transfusion segment holds the largest market
share owing to significant success rate and increasing adoption of this
treatment option.
The market by
end user, has been segmented into hospitals & clinics, diagnostics
laboratories, and others.
On the basis of
region, the global hemoglobinopathies market is segmented into the Americas,
Europe, Asia-Pacific, and the Middle East and Africa.
Hemoglobinopathies
Market Regional Analysis
The global
hemoglobinopathies market has been segmented, by region, into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa. The hemoglobinopathies
market in the Americas has further been segmented into North America and South
America, with the North America market further classified into the US and
Canada.
The European
hemoglobinopathies market has been segmented into Western Europe and Eastern
Europe. Western Europe has further been classified as Germany, France, the UK,
Italy, Spain, and the rest of Western Europe.
The
hemoglobinopathies market in Asia-Pacific has been segmented into Japan, China,
India, South Korea, Australia, and the rest of Asia-Pacific.
The
hemoglobinopathies market in the Middle East & Africa has been segmented
into the Middle East and Africa.
Hemoglobinopathies
Market Players
·
Globus Medical, Inc. (U.S.)
·
Depuy Synthes Inc. (Johnson & Johnson) (U.S.)
·
Smith & Nephew plc. (UK)
·
NuVasive, Inc. (U.S.)
·
Stryker Corporation (U.S.)
·
Integra LifeSciences Holdings Corporation (U.S.)
·
Zimmer Biomet Holdings, Inc. (U.S.)
·
Medtronic, plc (Ireland)
·
Wright Medical Group N.V. (Netherlands)
·
The Orthopedic Implant Company (U.S.)
·
Aesculap Implant Systems (U.S.)
·
Conmed Corporation (U.S.)
·
BioTek Instruments, Inc. (U.S.)
·
Arthrocare Corporation (U.S.)
among others
are some key companies in the global Hemoglobinopathies that are listed by MRFR
for market research.
Browse Detailed
TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/hemoglobinopathies-market-8098
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private
Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Comments
Post a Comment